BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9732374)

  • 1. Transport of L-valine-acyclovir via the oligopeptide transporter in the human intestinal cell line, Caco-2.
    de Vrueh RL; Smith PL; Lee CP
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1166-70. PubMed ID: 9732374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter: competitive inhibition of glycylsarcosine transport in human intestinal cell line-Caco-2.
    Anand BS; Patel J; Mitra AK
    J Pharmacol Exp Ther; 2003 Feb; 304(2):781-91. PubMed ID: 12538834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression in the human intestine and correlation with oral valacyclovir pharmacokinetic parameters.
    Landowski CP; Sun D; Foster DR; Menon SS; Barnett JL; Welage LS; Ramachandran C; Amidon GL
    J Pharmacol Exp Ther; 2003 Aug; 306(2):778-86. PubMed ID: 12750437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter.
    Han HK; Oh DM; Amidon GL
    Pharm Res; 1998 Sep; 15(9):1382-6. PubMed ID: 9755889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line.
    Guo A; Hu P; Balimane PV; Leibach FH; Sinko PJ
    J Pharmacol Exp Ther; 1999 Apr; 289(1):448-54. PubMed ID: 10087037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of novel dipeptide ester prodrugs of acyclovir after oral administration: intestinal absorption and liver metabolism.
    Anand BS; Katragadda S; Mitra AK
    J Pharmacol Exp Ther; 2004 Nov; 311(2):659-67. PubMed ID: 15226381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bifunctional peptidomimetic prodrugs of didanosine for improved intestinal permeability and enhanced acidic stability: synthesis, transepithelial transport, chemical stability and pharmacokinetics.
    Yan Z; Sun J; Chang Y; Liu Y; Fu Q; Xu Y; Sun Y; Pu X; Zhang Y; Jing Y; Yin S; Zhu M; Wang Y; He Z
    Mol Pharm; 2011 Apr; 8(2):319-29. PubMed ID: 21280612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition of L-amino acid ester compounds by rat peptide transporters PEPT1 and PEPT2.
    Sawada K; Terada T; Saito H; Hashimoto Y; Inui KI
    J Pharmacol Exp Ther; 1999 Nov; 291(2):705-9. PubMed ID: 10525090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of valaciclovir.
    MacDougall C; Guglielmo BJ
    J Antimicrob Chemother; 2004 Jun; 53(6):899-901. PubMed ID: 15140857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2.
    Ganapathy ME; Huang W; Wang H; Ganapathy V; Leibach FH
    Biochem Biophys Res Commun; 1998 May; 246(2):470-5. PubMed ID: 9610386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino acid prodrugs of acyclovir as possible antiviral agents against ocular HSV-1 infections: interactions with the neutral and cationic amino acid transporter on the corneal epithelium.
    Anand BS; Katragadda S; Nashed YE; Mitra AK
    Curr Eye Res; 2004; 29(2-3):153-66. PubMed ID: 15512962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of corneal permeation of L-valyl ester of acyclovir: targeting the oligopeptide transporter on the rabbit cornea.
    Anand BS; Mitra AK
    Pharm Res; 2002 Aug; 19(8):1194-202. PubMed ID: 12240946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acyclovir prodrug for the intestinal di/tri-peptide transporter PEPT1: comparison of in vivo bioavailability in rats and transport in Caco-2 cells.
    Thomsen AE; Christensen MS; Bagger MA; Steffansen B
    Eur J Pharm Sci; 2004 Dec; 23(4-5):319-25. PubMed ID: 15567284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carrier-mediated intestinal absorption of valacyclovir, the L-valyl ester prodrug of acyclovir: 1. Interactions with peptides, organic anions and organic cations in rats.
    Sinko PJ; Balimane PV
    Biopharm Drug Dispos; 1998 May; 19(4):209-17. PubMed ID: 9604120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, metabolism and cellular permeability of enzymatically stable dipeptide prodrugs of acyclovir.
    Talluri RS; Samanta SK; Gaudana R; Mitra AK
    Int J Pharm; 2008 Sep; 361(1-2):118-24. PubMed ID: 18573320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, transport and pharmacokinetics of 5'-amino acid ester prodrugs of 1-beta-D-arabinofuranosylcytosine.
    Sun Y; Sun J; Shi S; Jing Y; Yin S; Chen Y; Li G; Xu Y; He Z
    Mol Pharm; 2009; 6(1):315-25. PubMed ID: 19115956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter.
    Han H; de Vrueh RL; Rhie JK; Covitz KM; Smith PL; Lee CP; Oh DM; Sadée W; Amidon GL
    Pharm Res; 1998 Aug; 15(8):1154-9. PubMed ID: 9706043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Peptide transporter family].
    Terada T; Inui K
    Tanpakushitsu Kakusan Koso; 2001 Apr; 46(5):621-8. PubMed ID: 11296359
    [No Abstract]   [Full Text] [Related]  

  • 19. alpha(2)-adrenergic receptors stimulate oligopeptide transport in a human intestinal cell line.
    Berlioz F; Maoret JJ; Paris H; Laburthe M; Farinotti R; Rozé C
    J Pharmacol Exp Ther; 2000 Aug; 294(2):466-72. PubMed ID: 10900220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous modulation of transport and metabolism of acyclovir prodrugs across rabbit cornea: An approach involving enzyme inhibitors.
    Katragadda S; Talluri RS; Mitra AK
    Int J Pharm; 2006 Aug; 320(1-2):104-13. PubMed ID: 16720085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.